Mirati Therapeutics, Inc.

GUGGENHEIM CAPITAL LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

33,462

Value ($000)

1,966

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	1,966	0.0%	33,462	12/31/2023
2023 Q3	11/14/2023	1,346	0.0%	30,905	9/30/2023
2023 Q2	8/11/2023	1,001	0.0%	27,703	6/30/2023
2023 Q1	5/11/2023	1,020	0.0%	27,438	3/31/2023
2022 Q4	2/14/2023	2,053	0.0%	45,313	12/31/2022
2022 Q3	11/14/2022	1,700	0.0%	24,340	9/30/2022
2022 Q2	8/15/2022	2,142	0.0%	31,910	6/30/2022
2022 Q1	5/16/2022	2,285	0.0%	27,800	3/31/2022
2021 Q4	2/14/2022	3,569	0.0%	24,332	12/31/2021
2021 Q3	11/15/2021	3,696	0.0%	20,895	9/30/2021
2021 Q2	8/13/2021	3,487	0.0%	21,588	6/30/2021
2021 Q1	5/13/2021	3,603	0.0%	21,036	3/31/2021
2020 Q4	2/16/2021	4,006	0.0%	18,241	12/31/2020
2020 Q3	11/13/2020	3,524	0.0%	21,222	9/30/2020
2020 Q2	8/14/2020	3,640	0.0%	31,878	6/30/2020
2020 Q1	6/2/2020	1,917	0.0%	24,937	3/31/2020
2019 Q4	2/20/2020	4,164	0.0%	32,316	12/31/2019